Abbott India: Announcement under Regulation 30 (LODR)-Change in Directorate | Value Research

Abbott India: Announcement under Regulation 30 (LODR)-Change in Directorate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (the Listing Regulations) we hereby inform you that upon recommendation of the Nomination and Remuneration Committee the Board of Directors at its Meeting held today i.e. August 10 2022 approved the re-appointment of Ms Shalini Kamath (DIN: 06993314) as an Independent Director for a term of 5 (five) years with effect from October 29 2022 subject to the approval of the Shareholders of the Company. Additional details required pursuant to the Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9 2015 and List/Comp/14/2018-19 dated June 20 2018 is enclosed as Annexure A.This is for your information and records.

Click here to view PDF


Other Categories